Endophthalmitis following intravitreal injections at a tertiary center: real-life data on incidence, risk factors, management strategies, and visual outcomes

Endophthalmitis following intravitreal injections at a tertiary center: real-life data on incidence, risk factors, management strategies, and visual outcomes

Abstract Purpose To investigate the incidence, contributing factors, management, and long-term outcomes of endophthalmitis following intravitreal injections performed in our clinic. Methods This retrospective study included all patients who received intravitreal bevacizumab, aflibercept, ranibizumab...

Full description

Saved in:
Bibliographic Details
Main Authors: Sebile Comcali, Yelda Yildiz Tasci, Mehmet Onen, Busra Gulhan, Muzaffer Sahin, Cemal Cavdarli, Omer Mustafa Bilgic, Mucella Arikan Yorgun, Yasin Toklu, Mehmet Numan Alp, Zeliha Yazar
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Ophthalmology
Subjects:
Intravitreal injection
Endophthalmitis
Bevacizumab
Ranibizumab
Aflibercept
Dexamethasone
Online Access:https://doi.org/10.1186/s12886-025-04093-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12886-025-04093-w

Similar Items